Home World News Efficacy of Romiplostim In the Treatment and Prevention of Recurrence of Persistent... World News Efficacy of Romiplostim In the Treatment and Prevention of Recurrence of Persistent Chemotherapy-Induced Thrombocytopenia By Ogkologos - March 26, 2026 346 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the RECITE study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Vitamin D Supplements Don’t Reduce Cancer Incidence, Trial Shows December 13, 2018 Copanlisib Could Be a Viable Therapeutic Option for Select PIK3CA-Mutated Cancers May 25, 2022 Partnership in a pandemic: how Credit Suisse delivered an incredible Charity... May 19, 2021 Capmatinib Shows Activity in Advanced NSCLC with a MET Exon 14... September 8, 2020 Load more HOT NEWS NExT: Advancing Promising Cancer Therapies from the Lab to Clinical Trials Tumour Signatures Defined by Next Generation Sequencing Are Linked to Clinical... Survival Benefit of Enfortumab Vedotin and Pembrolizumab Compared with Chemotherapy in... A call to action: how our Campaigns Ambassadors are shaping the...
